Which tech companies are preparing IPOs in the next few months and what it means for investors

The global market for initial public offerings is once again showing signs of momentum, with several high-profile technology and consumer companies preparing to list within the next few months. From Netskope in the United States seeking a valuation of up to $6.5 billion, to Groww in India filing updated papers with the Securities and Exchange Board of India, the pipeline of IPO candidates reflects both the strength of secular growth themes such as cybersecurity, fintech, artificial intelligence, and healthcare distribution, and the willingness of investors to selectively embrace risk in search of long-term returns. This revival comes after a period marked by cautious market sentiment and volatile performance among earlier listings, underlining the importance of careful timing and investor alignment.

Why is Netskope accelerating its IPO and what does its $6.5 billion target suggest about cybersecurity appetite?

Netskope has confidentially filed for an IPO in the United States and is preparing to offer nearly 48 million shares, a move that could raise close to $800 million. The company has emerged as one of the most prominent providers of secure access service edge platforms and data protection tools, both of which have become critical as enterprises accelerate their migration to the cloud. With global organizations seeking to secure hybrid workforces and distributed data environments, Netskope’s technology has found strong demand across sectors ranging from financial services to healthcare.

By seeking a valuation of around $6.5 billion, Netskope is effectively testing whether investors are willing to assign premium multiples to cybersecurity companies in an environment where spending is resilient but scrutiny on profitability is tightening. Comparable companies such as CrowdStrike Holdings, Inc. (NASDAQ: CRWD) and Palo Alto Networks, Inc. (NASDAQ: PANW) have demonstrated that cybersecurity remains one of the most attractive segments of enterprise software, although share prices have been sensitive to quarterly budget fluctuations. Market watchers point out that Netskope’s IPO could set the tone for how investors treat other cybersecurity issuers in the pipeline, particularly those with strong recurring revenues but limited profitability visibility.

How does Groww’s planned listing fit within India’s evolving fintech landscape and investor sentiment?

Groww, headquartered in Bengaluru, is expected to file updated IPO papers with SEBI and could seek a listing by November 2025. The investment platform has become one of the most popular choices for India’s growing base of retail investors, enabling direct access to equities, mutual funds, and exchange-traded funds. The timing of the IPO is significant because India’s fintech sector has been navigating a complex period. Paytm’s disappointing performance following its own IPO remains a cautionary tale, reminding investors that growth alone cannot guarantee long-term value creation.

For Groww, the challenge is to balance its strong user acquisition record with a credible roadmap to profitability. Analysts believe the company will highlight increasing monetization from mutual fund distribution and equity broking services. Institutional investors are expected to scrutinize operating margins and customer acquisition costs closely. Foreign institutional investors have shown mixed appetite for Indian tech and financial services in recent quarters, leading to net outflows, while domestic institutional investors, particularly mutual funds and insurers, have emerged as more consistent supporters of homegrown IPOs. The eventual pricing of Groww’s issue will depend heavily on how regulators, bankers, and anchor investors align on valuation.

Why is Medline Industries seen as a landmark private equity-backed IPO in the healthcare distribution space?

Medline Industries, the Illinois-based distributor of medical and surgical products, is preparing for one of the largest U.S. IPOs in years, with the potential to raise between $4 billion and $5 billion. Backed by private equity firms Blackstone, Carlyle, and Hellman & Friedman, the company generates annual revenues in excess of $20 billion and supplies hospitals, clinics, and long-term care centers with a broad range of consumables and devices.

The IPO will be closely watched because private equity-backed companies have faced growing scrutiny over leverage, transparency, and post-listing performance. Investors will be keen to understand how much of the offering will involve secondary sales by existing sponsors and how much new capital will be raised to reduce debt or fund expansion. Comparisons with peers such as McKesson Corporation (NYSE: MCK) and Cardinal Health, Inc. (NYSE: CAH) suggest that Medline will need to justify a premium valuation based on its scale, distribution reach, and operational efficiency. The listing could mark a turning point in how large healthcare distributors are valued, particularly at a time when hospitals are under cost pressures but demand for medical supplies remains strong.

Could LG Electronics’ India arm IPO reshape investor access to the consumer electronics boom?

LG Electronics is planning to list its Indian subsidiary, potentially in October 2025, with a targeted raise of around ₹15,000 crore. The move would give global investors direct exposure to India’s rapidly expanding consumer electronics market. With a strong footprint in televisions, appliances, and air conditioning units, LG has built brand equity that positions it well against domestic players and international rivals.

For investors, the IPO represents an opportunity to participate in India’s consumption growth story, which is underpinned by a rising middle class and increasing disposable incomes. The valuation will likely be compared against established listed peers such as Voltas Ltd (NSE: VOLTAS) and Whirlpool of India Ltd (NSE: WHIRLPOOL). Analysts expect robust demand from retail investors, while foreign institutional participation will hinge on how attractively the issue is priced relative to consumer staples and discretionary stocks already trading at elevated multiples. The listing could further diversify India’s IPO landscape, which has been dominated in recent years by technology and financial services.

What hurdles must OpenAI overcome before pursuing a potential public listing?

OpenAI has become one of the most discussed potential IPO candidates globally, thanks to the success of ChatGPT and its growing suite of AI tools. Despite strong revenue growth from enterprise subscriptions and developer integrations, the company faces significant hurdles before an IPO can realistically take place. The hybrid nonprofit-for-profit structure has created governance complexities, while the capital-intensive nature of training and deploying advanced models has raised questions about sustainability.

A recent memorandum of understanding with Microsoft Corporation (NASDAQ: MSFT), OpenAI’s largest investor and strategic partner, has reportedly helped clarify certain ownership and licensing arrangements. However, analysts caution that regulatory scrutiny, competitive threats from Alphabet Inc. (NASDAQ: GOOGL) and Anthropic, and the broader debate about AI safety and compliance could delay any IPO plans. While some market observers believe OpenAI could move quickly to capture investor enthusiasm, others argue that resolving governance and cost structure challenges will be critical before entering public markets.

How are macroeconomic conditions and institutional flows shaping the timing of these IPOs?

The appetite for new listings is being shaped by global macroeconomic conditions. In the United States, equity markets have steadied following periods of volatility, though interest rate uncertainty continues to influence institutional behavior. Hedge funds and long-only investors are selectively positioning for high-growth names in cybersecurity and artificial intelligence, but valuation discipline remains strict.

In India, the Nifty 50 index remains near record highs, supported by strong domestic inflows even as foreign institutions have shown caution. Data suggests that FIIs have been net sellers in segments such as financial technology, while DIIs have been consistent buyers, offsetting volatility. The IPOs of Groww and LG Electronics’ India arm will serve as tests of how much incremental capital both foreign and domestic investors are willing to allocate toward high-growth but still evolving business models.

What lessons from past IPO cycles can guide investor decision-making in the coming months?

The last two years of IPO activity have demonstrated that not all high-profile listings deliver value. Companies such as Rivian Automotive, Inc. (NASDAQ: RIVN) and One 97 Communications Ltd (NSE: PAYTM) showed how hype can lead to sharp post-listing declines when valuations are stretched. Conversely, more disciplined offerings such as Arm Holdings plc (NASDAQ: ARM) showed that investors will support listings when strategic importance, financial performance, and pricing discipline align.

For Netskope, Groww, Medline, LG Electronics, and OpenAI, the lessons are clear. Investors will reward strong business fundamentals, clear profitability pathways, and realistic valuations. The pipeline of IPOs in late 2025 offers exposure to transformative sectors, but discerning between hype and value will be crucial. For institutional investors, the decision is less about whether to participate and more about at what price and under what allocation. Retail investors, meanwhile, must weigh long-term prospects against the risk of near-term volatility.

As the next wave of IPOs unfolds, the defining question will be whether markets are ready to absorb ambitious offerings across multiple geographies and sectors. Success will depend on a balance of investor discipline, company execution, and macroeconomic stability. If managed well, this phase could mark the beginning of a more sustainable IPO cycle rather than a speculative bubble.